ROBERT J PEREZ
CIK 1263230 · Chief Executive Officer · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$136.6K
Companies
12
Total Filings
111
Lifetime Open-Market Net
-$15.17M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RAPP | Director | — | $40.94 | — | $0 | 3 | 2026-06-10 |
| VIR | Director | 15,806 | $8.64 | $136.6K | $0 | 5 | 2023-05-24 |
| Third Harmonic Bio, Inc. (THRD) Delisted | Director | — | $5.38 | — | $0 | 2 | 2023-03-08 |
| Spark Therapeutics, Inc. (ONCE) Delisted | Director | 0 | — | — | $0 | 5 | 2019-12-17 |
| Larimar Therapeutics, Inc. (ZFGN) Delisted | Director | 908 | — | — | $0 | 10 | 2019-06-27 |
| Cogent Biosciences, Inc. (UMRX) Delisted | Director | — | — | — | $0 | 5 | 2019-06-18 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Director | 33,629 | — | — | $0 | 12 | 2019-05-20 |
| Salarius Pharmaceuticals, Inc. (FLKS) Delisted | Director | — | — | — | $0 | 3 | 2017-07-27 |
| Cidara Therapeutics, Inc. (CDTX) Delisted | Director | 250 | $221.38 | $55.3K | $80.0K | 4 | 2017-06-26 |
| CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted | Chief Executive Officer | 0 | — | — | -$6.98M | 10 | 2015-01-21 |
| CUBIST PHARMACEUTICALS INC (CBST) Delisted | President & COO | 43,359 | — | — | -$8.27M | 48 | 2013-08-16 |
| EPIX Pharmaceuticals, Inc. (EPIX) Delisted | Director | — | $0.20 | — | $0 | 2 | 2008-05-21 |
Recent Filings · Page 11 of 12
111 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-04-02 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Other (J) | +489 | $9.0K | EDGAR |
| 2008-02-19 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-01-07 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Other (J) | +502 | $8.6K | EDGAR |
| 2007-10-02 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Other (J) | +77 | $1.6K | EDGAR |
| 2007-09-18 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-08-24 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-07-03 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Other (J) | +996 | $15.2K | EDGAR |
| 2007-07-02 | EPIX Pharmaceuticals, Inc. (EPIX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-04-03 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Other (J) | +268 | $5.9K | EDGAR |
| 2007-02-16 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.